Cargando…

Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the principal risk factor associated to end-stage liver diseases in the world. A study was carried out on end-stage liver disease cases admitted to an important hepatology unit in Medellin, the second largest city in Colombia. From 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortes-Mancera, Fabian, Loureiro, Carmen Luisa, Hoyos, Sergio, Restrepo, Juan-Carlos, Correa, Gonzalo, Jaramillo, Sergio, Norder, Helene, Pujol, Flor Helene, Navas, Maria-Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177233/
https://www.ncbi.nlm.nih.gov/pubmed/21941645
http://dx.doi.org/10.1155/2011/363205
_version_ 1782212285613211648
author Cortes-Mancera, Fabian
Loureiro, Carmen Luisa
Hoyos, Sergio
Restrepo, Juan-Carlos
Correa, Gonzalo
Jaramillo, Sergio
Norder, Helene
Pujol, Flor Helene
Navas, Maria-Cristina
author_facet Cortes-Mancera, Fabian
Loureiro, Carmen Luisa
Hoyos, Sergio
Restrepo, Juan-Carlos
Correa, Gonzalo
Jaramillo, Sergio
Norder, Helene
Pujol, Flor Helene
Navas, Maria-Cristina
author_sort Cortes-Mancera, Fabian
collection PubMed
description Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the principal risk factor associated to end-stage liver diseases in the world. A study was carried out on end-stage liver disease cases admitted to an important hepatology unit in Medellin, the second largest city in Colombia. From 131 patients recruited in this prospective study, 71% of cases were diagnosed as cirrhosis, 12.2% as HCC, and 16.8% as cirrhosis and HCC. Regarding the risk factors of these patients, alcohol consumption was the most frequent (37.4%), followed by viral etiology (17.6%). Blood and/or hepatic tissue samples from patients with serological markers for HCV or HBV infection were characterized; on the basis of the phylogenetic analysis of HCV 5′ UTR and HBV S gene, isolates belonged to HCV/1 and HBV/F3, respectively. These results confirm the presence of strains associated with poor clinical outcome, in patients with liver disease in Colombia; additionally, HBV basal core promoter double mutant was identified in HCC cases. Here we show the first study of cirrhosis and/or HCC in Colombian and HBV and HCV molecular characterization of these patients. Viral aetiology was not the main risk factor in this cohort but alcohol consumption.
format Online
Article
Text
id pubmed-3177233
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31772332011-09-22 Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia Cortes-Mancera, Fabian Loureiro, Carmen Luisa Hoyos, Sergio Restrepo, Juan-Carlos Correa, Gonzalo Jaramillo, Sergio Norder, Helene Pujol, Flor Helene Navas, Maria-Cristina Hepat Res Treat Research Article Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the principal risk factor associated to end-stage liver diseases in the world. A study was carried out on end-stage liver disease cases admitted to an important hepatology unit in Medellin, the second largest city in Colombia. From 131 patients recruited in this prospective study, 71% of cases were diagnosed as cirrhosis, 12.2% as HCC, and 16.8% as cirrhosis and HCC. Regarding the risk factors of these patients, alcohol consumption was the most frequent (37.4%), followed by viral etiology (17.6%). Blood and/or hepatic tissue samples from patients with serological markers for HCV or HBV infection were characterized; on the basis of the phylogenetic analysis of HCV 5′ UTR and HBV S gene, isolates belonged to HCV/1 and HBV/F3, respectively. These results confirm the presence of strains associated with poor clinical outcome, in patients with liver disease in Colombia; additionally, HBV basal core promoter double mutant was identified in HCC cases. Here we show the first study of cirrhosis and/or HCC in Colombian and HBV and HCV molecular characterization of these patients. Viral aetiology was not the main risk factor in this cohort but alcohol consumption. Hindawi Publishing Corporation 2011 2011-09-20 /pmc/articles/PMC3177233/ /pubmed/21941645 http://dx.doi.org/10.1155/2011/363205 Text en Copyright © 2011 Fabian Cortes-Mancera et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cortes-Mancera, Fabian
Loureiro, Carmen Luisa
Hoyos, Sergio
Restrepo, Juan-Carlos
Correa, Gonzalo
Jaramillo, Sergio
Norder, Helene
Pujol, Flor Helene
Navas, Maria-Cristina
Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
title Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
title_full Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
title_fullStr Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
title_full_unstemmed Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
title_short Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
title_sort etiology and viral genotype in patients with end-stage liver diseases admitted to a hepatology unit in colombia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177233/
https://www.ncbi.nlm.nih.gov/pubmed/21941645
http://dx.doi.org/10.1155/2011/363205
work_keys_str_mv AT cortesmancerafabian etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT loureirocarmenluisa etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT hoyossergio etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT restrepojuancarlos etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT correagonzalo etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT jaramillosergio etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT norderhelene etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT pujolflorhelene etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia
AT navasmariacristina etiologyandviralgenotypeinpatientswithendstageliverdiseasesadmittedtoahepatologyunitincolombia